Nephros (NEPH) Capital Expenditures (2010 - 2022)

Nephros has reported Capital Expenditures for 6 years, with the latest figure at $103000.0 in Q2 2022.

• On a quarterly basis, Capital Expenditures changed N/A year-over-year to $103000.0 in Q2 2022; TTM through Sep 2024 was $103000.0, a N/A change from a year earlier, with the FY2024 full-year figure at $55000.0, down 26.67% from the prior year.
• Capital Expenditures was $103000.0 for Q2 2022 at Nephros, up from $34000.0 in the prior quarter.
• The five-year high for Capital Expenditures was $103000.0 in Q2 2022, with the low at $13000.0 in Q3 2020.
• Average Capital Expenditures over 3 years is $37200.0, with a median of $23000.0 recorded in 2021.
• The sharpest annual moves came in 2021 and 2022: Capital Expenditures changed 0.0% in 2021, then soared 47.83% in 2022.
• Over 3 years, Capital Expenditures stood at $13000.0 in 2020, then changed by 0.0% to $13000.0 in 2021, then jumped by 692.31% to $103000.0 in 2022.
• The last three Capital Expenditures figures came in at $103000.0 (Q2 2022), $34000.0 (Q1 2022), and $13000.0 (Q3 2021), per Business Quant data.